Resuscitative Endovascular Balloon Occlusion of the Aorta: Assessing Need in an Urban Trauma Center.


Journal

The Journal of surgical research
ISSN: 1095-8673
Titre abrégé: J Surg Res
Pays: United States
ID NLM: 0376340

Informations de publication

Date de publication:
01 2019
Historique:
received: 12 02 2018
revised: 07 07 2018
accepted: 14 08 2018
entrez: 4 12 2018
pubmed: 7 12 2018
medline: 14 11 2019
Statut: ppublish

Résumé

Resuscitative endovascular balloon occlusion of the aorta (REBOA) has emerged as a bridge to definitive hemostasis in select patients with noncompressible torso hemorrhage. The number of patients who might benefit from this procedure, however, remains incompletely defined. We hypothesized that we could quantify the number of patients presenting to our center over a 2-year period who may have benefited from REBOA. All patients presenting to our trauma center from 2014 to 2015 were included. Potential REBOA patients were identified based on anatomic injuries. We used ICD-9 codes to identify REBOA-amenable injury patterns and physiology. We excluded patients with injuries contraindicating REBOA. We then used chart review by two REBOA-experienced independent reviewers to assess each potential REBOA candidate, evaluate the accuracy of our algorithm, and to identify a cohort of confirmed REBOA candidates. Four thousand eight hundred eighteen patients were included of which 666 had injuries potentially amenable to REBOA. Three hundred thirty-five patients were hemodynamically unstable, and 309 patients had contraindications to REBOA. Sixty-four patients had both injury patterns and physiology amenable to REBOA with no contraindications, and these patients were identified as potential REBOA candidates. Of these, detailed independent two physician chart review identified 29 patients (45%) as confirmed REBOA candidates (interrater reliability kappa = 0.94, P < 0.001). Our database query identified patients with indications for REBOA but overestimated the number of REBOA candidates. To accurately quantify the REBOA candidate population at a given center, an algorithm to identify potential patients should be combined with chart review. Therapeutic study, level V.

Sections du résumé

BACKGROUND
Resuscitative endovascular balloon occlusion of the aorta (REBOA) has emerged as a bridge to definitive hemostasis in select patients with noncompressible torso hemorrhage. The number of patients who might benefit from this procedure, however, remains incompletely defined. We hypothesized that we could quantify the number of patients presenting to our center over a 2-year period who may have benefited from REBOA.
METHODS
All patients presenting to our trauma center from 2014 to 2015 were included. Potential REBOA patients were identified based on anatomic injuries. We used ICD-9 codes to identify REBOA-amenable injury patterns and physiology. We excluded patients with injuries contraindicating REBOA. We then used chart review by two REBOA-experienced independent reviewers to assess each potential REBOA candidate, evaluate the accuracy of our algorithm, and to identify a cohort of confirmed REBOA candidates.
RESULTS
Four thousand eight hundred eighteen patients were included of which 666 had injuries potentially amenable to REBOA. Three hundred thirty-five patients were hemodynamically unstable, and 309 patients had contraindications to REBOA. Sixty-four patients had both injury patterns and physiology amenable to REBOA with no contraindications, and these patients were identified as potential REBOA candidates. Of these, detailed independent two physician chart review identified 29 patients (45%) as confirmed REBOA candidates (interrater reliability kappa = 0.94, P < 0.001).
CONCLUSIONS
Our database query identified patients with indications for REBOA but overestimated the number of REBOA candidates. To accurately quantify the REBOA candidate population at a given center, an algorithm to identify potential patients should be combined with chart review.
STUDY TYPE
Therapeutic study, level V.

Identifiants

pubmed: 30502280
pii: S0022-4804(18)30600-0
doi: 10.1016/j.jss.2018.08.031
pmc: PMC6713903
mid: NIHMS1044538
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

413-419

Subventions

Organisme : NHLBI NIH HHS
ID : K08 HL131995
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

J Trauma Acute Care Surg. 2015 May;78(5):1054-8
pubmed: 25909430
J Trauma Acute Care Surg. 2012 Dec;73(6 Suppl 5):S431-7
pubmed: 23192066
J Trauma Acute Care Surg. 2013 Mar;74(3):830-4
pubmed: 23425743
Shock. 2014 May;41(5):388-93
pubmed: 25133599
J Trauma Acute Care Surg. 2014 Aug;77(2):286-91
pubmed: 25058255
Crit Care Clin. 2017 Jan;33(1):55-70
pubmed: 27894499
Crit Care. 2005;9 Suppl 5:S1-9
pubmed: 16221313
J Surg Res. 2013 Sep;184(1):414-21
pubmed: 23831230
Lancet. 2009 Sep 26;374(9695):1105-12
pubmed: 19782876
BMJ. 1998 Apr 25;316(7140):1310-3
pubmed: 9554906
J Emerg Med. 2018 Apr;54(4):419-426
pubmed: 29456087
J Trauma Acute Care Surg. 2016 Nov;81(5 Suppl 2 Proceedings of the 2015 Military Health System Researc):S128-S132
pubmed: 27768660
Trauma Surg Acute Care Open. 2018 Jan 13;3(1):e000154
pubmed: 29766135
Emerg Med J. 2015 Dec;32(12):926-32
pubmed: 26598631
J Trauma. 2011 Dec;71(6):1869-72
pubmed: 22182896
Health Econ. 2017 Feb;26 Suppl 1:109-123
pubmed: 28139090
J Trauma Acute Care Surg. 2016 Sep;81(3):409-19
pubmed: 27050883
JAMA. 2016 Dec 13;316(22):2347
pubmed: 27959984
Lancet. 2009 Sep 26;374(9695):1089-96
pubmed: 19782874
J Surg Res. 2012 Oct;177(2):341-7
pubmed: 22591921
J Trauma Acute Care Surg. 2016 Feb;80(2):324-34
pubmed: 26816219
J Trauma Acute Care Surg. 2014 Apr;76(4):929-35; discussion 935-6
pubmed: 24662854
J Trauma Acute Care Surg. 2017 Oct;83(4):732-735
pubmed: 28930964

Auteurs

Ryan P Dumas (RP)

Division of Traumatology, Surgical Critical Care and Emergency Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: ryan.dumas@utsouthwestern.edu.

Daniel N Holena (DN)

Division of Traumatology, Surgical Critical Care and Emergency Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Brian P Smith (BP)

Division of Traumatology, Surgical Critical Care and Emergency Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Daniel Jafari (D)

Division of Traumatology, Surgical Critical Care and Emergency Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Department of Emergency Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Mark J Seamon (MJ)

Division of Traumatology, Surgical Critical Care and Emergency Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Patrick M Reilly (PM)

Division of Traumatology, Surgical Critical Care and Emergency Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Zaffer Qasim (Z)

Department of Emergency Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Jeremy W Cannon (JW)

Division of Traumatology, Surgical Critical Care and Emergency Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH